This project will examine the effect of providing access to self-administered injectable contraception in the form of depo-subQ Provera 104 and text-based injection reminders on unintended pregnancy rates among users of depo-medroxyprogesterone acetate at Hurley Medical Center, a publicly funded safety-net hospital in Flint, Michigan. This project will compare unintended pregnancy rates among the study group to a historical cohort. The goal of this project is to ultimately re-frame the way we conceptualize contraceptive effectiveness and encourage providers and researchers to turn greater attention to the true contraceptive preferences of patients and work to optimize a patient’s method of choice. Through this project, we hope to work towards increasing patient autonomy and empowerment while increasing access to contraception in a way that also maximizes its effectiveness.